Synthesis of clinical trials evaluating regenerative, minimally invasive treatments for female stress urinary incontinence, focusing on symptom, objective, and quality-of-life outcomes.
Key Takeaways
- Total of 19 studies encompassing 591 patients were included
- Loss to follow-up rate and adverse events were no more than 8%
- Significant heterogeneity was observed across all outcome measures